Largest companies by net assets
net assets
| Company | Net assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 201 | $23.91M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 202 | $23.47M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 203 | $20.68M | Healthcare | Pharmaceuticals | United States | NYSE |
| 204 | $19.18M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 205 | $18.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 206 | $18.22M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 207 | $18.20M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 208 | $16.86M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 209 | $16.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 210 | $16.29M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 211 | $16.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 212 | $15.10M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 213 | $14.80M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 214 | $14.47M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 215 | $14.41M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 216 | $13.47M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 217 | $12.64M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 218 | $12.60M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 219 | $12.51M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 220 | $12.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 221 | $12.15M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 222 | $11.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 223 | $11.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 224 | $11.44M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 225 | $11.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 226 | $11.29M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 227 | $10.94M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 228 | $10.40M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 229 | $10.29M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 230 | $10.28M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 231 | $10.27M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 232 | $10.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 233 | $9.04M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 234 | $8.81M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 235 | $8.38M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 236 | $8.20M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 237 | $8.16M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 238 | $8.15M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 239 | $8.08M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 240 | $7.94M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 241 | $7.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 242 | $7.43M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 243 | $6.99M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 244 | $6.82M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 245 | $6.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 246 | $6.65M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 247 | $6.13M | Healthcare | Pharmaceuticals | United States | NYSE |
| 248 | $6.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 249 | $6.04M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 250 | $5.96M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 251 | $5.80M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 252 | $5.51M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 253 | $5.03M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 254 | $5.00M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 255 | $4.89M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 256 | $4.79M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 257 | $4.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 258 | $4.64M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 259 | $4.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 260 | $4.33M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 261 | $4.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 262 | $4.31M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 263 | $4.25M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 264 | $4.19M | Healthcare | Pharmaceuticals | United States | NYSE |
| 265 | $4.19M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 266 | $4.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 267 | $3.67M | Healthcare | Pharmaceuticals | United States | NYSE |
| 268 | $3.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 269 | $3.49M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 270 | $3.20M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 271 | $3.12M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 272 | $2.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 273 | $2.56M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 274 | $2.31M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 275 | $1.91M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 276 | $1.80M | Healthcare | Pharmaceuticals | United States | NYSE |
| 277 | $1.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 278 | $1.08M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 279 | $1.04M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 280 | $0.99M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 281 | $0.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 282 | $0.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 283 | $0.65M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 284 | $0.00M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 285 | $-0.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 286 | $-0.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 287 | $-0.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 288 | $-0.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 289 | $-0.56M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 290 | $-0.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 291 | $-0.78M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 292 | $-1.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 293 | $-1.24M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 294 | $-1.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 295 | $-1.78M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 296 | $-3.22M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 297 | $-3.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 298 | $-4.25M | Healthcare | Pharmaceuticals | United States | NYSE |
| 299 | $-6.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 300 | $-9.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 333 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.